NOAEL Studies
Cosmetic Ingredient
Hydroxyethyl-2-Nitro-p-Toluidine NOAEL Studies
INCI: HYDROXYETHYL-2-NITRO-P-TOLUIDINE
CAS: 100418-33-5
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
SCCS Opinion 9 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =0.04 | mg/kg bw/d | rat | oral | 90 day | dermal absorption | p.26 |
| SCCS Opinion | NOAEL | =0.05 | mg/kg bw/d | rat | oral | 90 day | dermal absorption | p.26 |
| SCCS Opinion | NOAEL | =45 | mg/kg bw | - | - | Chronic | genotoxicity | Ref.: 21 (submission I, ref 9) 3, p.15 |
| SCCS Opinion | NOAEL | =45 | mg/kg bw/day | rat | - | 90-day | dermal absorption | p.21 |
| SCCS Opinion | NOAEL | =45 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.20 |
| SCCS Opinion | NOAEL | =45 | mg/kg bw/d | rat | oral | 90 day | dermal absorption | p.26 |
| SCCS Opinion | NOAEL | =90 | mg/kg bw | - | - | Chronic | genotoxicity | Ref.: 21 (submission I, ref 9) 3, p.15 |
| SCCS Opinion | NOAEL | =90 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.20 |
| SCCS Opinion | NOAEL | =240 | mg/kg bw/day | rat | oral | Sub-chronic | repeated dose toxicity | p.14 |
ECHA 3 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ECHA | NOAEL | =60 | mg/kg bw/day | Rat | oral | - | developmental | QUALITY=1 (reliable without restriction); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/669eabace4b0a7c65d1bb306; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/en/registration-dossier/-/registered-dossier/9108?documentUUID=7656cd6b-cc29-4d91-bc42-958ce3e398e2; YEAR=2017; ORIGINAL_YEAR=2017; STUDY_GROUP=ECHA IUCLID:15821589:M/F:-fetal; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_acb7ab4295d69d5368b442ab7980105b |
| ECHA | NOAEL | =90 | mg/kg bw/day | Rat | oral | subchronic; 90 days | subchronic | QUALITY=1 (reliable without restriction); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/669eaca9e4b0a7c65d1c026f; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/en/registration-dossier/-/registered-dossier/9108?documentUUID=7656cd6b-cc29-4d91-bc42-958ce3e398e2; YEAR=2017; ORIGINAL_YEAR=2017; STUDY_GROUP=ECHA IUCLID:15838374:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_8a0aa9ad70f065276cee4d59a5b77ffd |
| ECHA | NOAEL | =240 | mg/kg bw/day | Rat | oral | short-term; 4 weeks | short-term | QUALITY=1 (reliable without restriction); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/669eaca9e4b0a7c65d1c0271; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/en/registration-dossier/-/registered-dossier/9108?documentUUID=7656cd6b-cc29-4d91-bc42-958ce3e398e2; YEAR=2017; ORIGINAL_YEAR=2017; TOXICOLOGICAL_EFFECT=clinical biochemistry|organ weights and organ / body weight ratios|urinalysis; TOXICOLOGICAL_EFFECT_CATEGORY=clinical chemistry|organ weight|urinalysis; STUDY_GROUP=ECHA IUCLID:15842773:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_7c2b53302bd489767eda65f288fad9ba |
Regulatory source 11 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 45 | mg/kg bw/day | rat | oral | 90-day | - | p.27 |
| Regulatory source | dermal absorption | =0.04 | mg/kg bw/d | rat | oral | 90 day | dermal absorption | p.26 |
| Regulatory source | dermal absorption | =0.05 | mg/kg bw/d | rat | oral | 90 day | dermal absorption | p.26 |
| Regulatory source | dermal absorption | 45 | mg/kg bw/day | rat | - | 90-day | dermal absorption | p.21 |
| Regulatory source | dermal absorption | =45 | mg/kg bw/d | rat | oral | 90 day | dermal absorption | p.26 |
| Regulatory source | genotoxicity | 45 | mg/kg bw | - | - | Chronic | genotoxicity | p.15 |
| Regulatory source | genotoxicity | 45 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.20 |
| Regulatory source | genotoxicity | 45 | mg/kg bw/day | rat | oral | 90-day | genotoxicity | p.27 |
| Regulatory source | genotoxicity | 90 | mg/kg bw | - | - | Chronic | genotoxicity | p.15 |
| Regulatory source | genotoxicity | 90 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.20 |
| Regulatory source | repeated dose toxicity | 240 | mg/kg bw/day | rat | oral | Sub-chronic | repeated dose toxicity | p.14 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | KL22OLP94K | UNII | - | - | - | chemical | - |